BackNewAmsterdam Pharma Company NV Overview

NewAmsterdam Pharma Company NV Operating Income

Operating Income for NAMS.

Quarterly Operating Income

$-58420000.00
↓ 15.24% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-215178000.00
↑ 13.41% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin